“Providing
best in class technology helps us to remain competitive. We are pleased
to offer EOS to not only our patients, but also to our referring
doctors. They appreciate that EOS exams are safe and provide more data
than alternative imaging devices.”

EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI -
Eligible PEA - PME), the pioneer of 2D/3D imaging and data solutions for
orthopedics, today announced the installation of an EOS® system at the
Queensland X-Ray radiology practice in the Gold Coast Private Hospital
in Southport, Gold Coast, Australia. The system placement is the sixth
installation in the last 12 months in Australia. In addition, this
installation is the 15th for EOS imaging in Australia, and
the 13th system at a private facility in the country.

Queensland X-Ray is one of the largest private radiology groups in the
state of Queensland and is part of Sonic Healthcare, an Australia-based
global healthcare company. Sonic Healthcare is a leading provider of
radiology services in Australia. The Gold Coast Private Hospital opened
in March 2016 and offers a full range of services that address both the
adult and pediatric populations, with 284 beds and 13 operating
theatres. The new Healthscope hospital is co-located with the Gold Coast
University Hospital and Griffith University, forming a major part of the
Gold Coast's new 'Health and Knowledge Precinct', an emerging health and
innovation hub.

“We are committed to providing the best service, care and clinical
outcome for our patients,” said Dr Ryan Shulman at Queensland X-Ray. “Providing
best in class technology helps us to remain competitive. We are pleased
to offer EOS to not only our patients, but also to our referring
doctors. They appreciate that EOS exams are safe and provide more data
than alternative imaging devices.”

“We are seeing an increased interest in the EOS technology from
private practices in several of our key markets,” commented Marie
Meynadier, CEO of EOS imaging. “The amount of clinical validation
supporting our technology is establishing it as a growing standard of
care for imaging across the spectrum of orthopedic point of care
organizations. We are proud of our expanding footprint in Australia and
of serving patients and physicians there with our low dose, full body
2D/3D solutions.”

About EOS imaging

EOS imaging designs, develops and markets EOS®, a major innovative
medical imaging solution dedicated to osteoarticular pathologies and
orthopaedics combining equipment and services and targeting a $2B per
year market opportunity. EOS imaging is currently present in 31
countries, including the United States under FDA agreement, Japan, China
and the European Union under CE labelling, through the over 250
installed EOS® platforms representing around one million patient exams
every year. Revenues were €37.1M in 2017, e.g. a +32% CAGR over
2012-2017.